Lower taxes better than price controls, says Brazilian industry
This article was originally published in Scrip
Executive Summary
Manufacturers in Brazil will be able to increase their drug prices by a maximum of 5.9%, says Cmed, which regulates the prices of medicines. However, Febrafarma, Brazil's pharmaceutical industry federation, argues that reducing the taxes imposed on medicines would be more effective in widening access to medicines than price controls.